17
Frequently Asked Questions Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify that AstraZeneca owns the rights to reuse these assets/components and any files that are part of them for the context, location, and duration of your intended use. Last Edit: July 14, 2017 Page 1 Table of Contents About Content Centre Why was Content Centre developed? Why is it beneficial? Why should I use the materials in Content Centre? What are the metrics for success in Content Centre? Accessing Content Centre How do I access Content Centre? What is the process for requesting Content Centre access for outside agencies? How do I gain access to the security group for medical assets on Content Centre? What measures are in place to prevent commercial teams from viewing medical assets? Can medical affairs personnel access commercial content? Is Content Centre available in other languages? Asset Availability and Planning What are Validated Assets and Non-Validated Assets? How do I know when a new asset has reached Content Centre? Can Non-Validated Assets be reused? What types of assets will be available? How can I be sure I’m accessing the most recently approved assets? Can images be changed? Who populates the planning calendar? How do global teams evaluate which assets will be promoted to Content Centre? What is the process for GPPS/GCA and their Agency of Record (AoR) to obtain Global Nominated Signatory approval? I don’t see my brand on Content Centre. How do I find out if/when my brand will be available? Are assets available for all local markets? How will an asset that has been approved globally be handled though the local approval process? Will assets be available in my language?

Frequently Asked Questions Table of Contents · Frequently Asked Questions Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify

  • Upload
    others

  • View
    6

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Frequently Asked Questions Table of Contents · Frequently Asked Questions Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify

Frequently Asked Questions

Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify that

AstraZeneca owns the rights to reuse these assets/components and any files that are part of them for the context, location, and duration of your intended use.

Last Edit: July 14, 2017 Page 1

Table of Contents

About Content Centre Why was Content Centre developed? Why is it beneficial?

Why should I use the materials in Content Centre?

What are the metrics for success in Content Centre?

Accessing Content Centre How do I access Content Centre?

What is the process for requesting Content Centre access for outside agencies?

How do I gain access to the security group for medical assets on Content Centre?

What measures are in place to prevent commercial teams from viewing medical assets?

Can medical affairs personnel access commercial content?

Is Content Centre available in other languages?

Asset Availability and Planning

What are Validated Assets and Non-Validated Assets?

How do I know when a new asset has reached Content Centre?

Can Non-Validated Assets be reused?

What types of assets will be available?

How can I be sure I’m accessing the most recently approved assets?

Can images be changed?

Who populates the planning calendar?

How do global teams evaluate which assets will be promoted to Content Centre?

What is the process for GPPS/GCA and their Agency of Record (AoR) to obtain Global Nominated Signatory approval?

I don’t see my brand on Content Centre. How do I find out if/when my brand will be available?

Are assets available for all local markets?

How will an asset that has been approved globally be handled though the local approval process?

Will assets be available in my language?

Page 2: Frequently Asked Questions Table of Contents · Frequently Asked Questions Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify

Frequently Asked Questions

Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify that

AstraZeneca owns the rights to reuse these assets/components and any files that are part of them for the context, location, and duration of your intended use.

Last Edit: July 14, 2017 Page 2

If I am in a local market, can I upload my asset(s) into Content Centre for reuse in other markets?

Are there any specific assets that the local agencies should search for in Content Centre before developing it themselves?

How can I get the correct material, such as high resolution graphics, that must be sent to the agency?

Does the completed Metadata Request Form (MRF) allow us to use the asset at local level with all copyrights required?

Is learning content also available on Content Centre?

Who can I contact if I cannot find the learning material I am looking for?

Can I access learning material if I have already done promotional learner training?

How are learning materials displayed on Content Centre?

How do I recognise a medical asset versus a commercial one?

Content Packs What is a Content Pack?

What is the point / benefit of a Content Pack?

What if I would like an asset that is not included in the standard Content Pack offering?

How can I influence what is offered in a Content Pack?

What does it cost?

How long does it take to prepare a Content Pack?

Are Content Packs globally approved?

Where can I look at the Content Packs that are already available?

How do I know what other Content Packs are coming?

What is the best way to localise the Content Pack assets?

Who can I talk to about working on and creating a Content Pack?

How do I access and download the Content Pack materials?

Download Logistics How long does it take to download the file?

Where do downloaded files end up?

What do I need to download? Should I include associated files or not?

Can the source file download option be made default?

Are the reference documents present on Validated Assets?

Page 3: Frequently Asked Questions Table of Contents · Frequently Asked Questions Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify

Frequently Asked Questions

Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify that

AstraZeneca owns the rights to reuse these assets/components and any files that are part of them for the context, location, and duration of your intended use.

Last Edit: July 14, 2017 Page 3

Support Who are the local Production Partners?

Is Content Centre going to make any content changes for the assets?

If the local marketing teams need help purchasing fonts, who do they reach out to?

What other services does Content Centre provide?

Training

Who do I contact if I have questions?

What training will be provided and when?

Are agencies able to register for trainings?

Are there unique trainings for promotional and learning content?

Page 4: Frequently Asked Questions Table of Contents · Frequently Asked Questions Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify

Frequently Asked Questions

Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify that

AstraZeneca owns the rights to reuse these assets/components and any files that are part of them for the context, location, and duration of your intended use.

Last Edit: July 14, 2017 Page 4

GDO Engagement Team

Regional Engagement Managers

Brazil & LatAm

SW Europe MEA, ANZ, Asia Area

NE Europe, Russia, Eurasia

China & Japan

Patricia Hamilton

Marta Matosas

Vinay Patel

Sybille Dihanich Toshiki Nakagawa

Market Delivery Leaders Global Engagement Directors

US Respiratory/

Est Brands

US Oncology

US CVMD

GPPS GPPS/

Canada

Brian

Moriarty

Mark Kurth

Lisa Britton

Nichola Menzel*

Rose Pimpinella**

* Brands supported by Nichola Menzel – BRILINTA, LYNPARZA, IRESSA, FASLODEX, TAGRISSO,

SYMBICORT, DUAKLIR / EKLIRA, DAXAS / DALIRESP

** Brands supported by Rose Pimpinella - FORXIGA, XIGDUO XR, BYDUREON, ONGLYZA, KOMBIGGLYZE

XR, QTERN, LOKELMA, Roxadustat, Durvalumab / Tremelimumab, Moxetumomab, Acalabrutinib, BEVESPI,

Benralizumab, Tralokiumab, Pearl - PT010, Anifrolumab

GDO ENGAGEMENT TEAM

Global Digital Organisation (GDO) is available to provide market level support for

localisation and translation. Please contact your Regional Engagement Manager,

Market Delivery Leader (US) or Global Engagement Director (GPPS) for information

on how to leverage these efficient, cost-effective services.

Regional Engagement Managers

Brazil & LatAm

SW Europe MEA, ANZ, Asia Area

NE Europe, Russia, Eurasia

China & Japan

Patricia Hamilton

Marta Matosas

Vinay Patel

Sybille Dihanich Toshiki Nakagawa

Page 5: Frequently Asked Questions Table of Contents · Frequently Asked Questions Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify

Frequently Asked Questions

Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify that

AstraZeneca owns the rights to reuse these assets/components and any files that are part of them for the context, location, and duration of your intended use.

Last Edit: July 14, 2017 Page 5

About Content Centre

Why was Content Centre developed? Why is it beneficial? Content Centre was created to help streamline content development across AstraZeneca. A 12-month

audit of assets revealed numerous duplications and redundancies in content. To reduce these

redundancies and provide a cost-effective way of obtaining and leveraging reusable assets, Global Digital

Organisation (GDO) launched Content Centre.

Content Center is a global capability that provides Global Portfolio and Product Strategy (GPPS)

approved content for use by local marketing companies. Content Center utilizes a global digital platform

where local marketing companies can access and download validated* content for localization and reuse.

Content Centre provides a new way of working and will function as an operational bridge between Global

teams and local marketing teams by working closely with the GDO Engagement Team to understand

local market needs. GDO will work closely with Global Product and Portfolio Strategies (GPPS), Global

Commercial Academy (GCA) and other teams to produce assets with validated content (i.e., approved by

Global Nominated Signatory with complete source files, reference lists, annotated citations, licenses, and

global rights). These globally approved assets allow the local marketing teams to more efficiently and

effectively reuse globally produced assets.

Previously only GPPS promotional materials were available as Validated Assets in Content Centre. Now,

Content Centre expanded to include Global Commercial Academy curricula and other eLearning assets

for growth and mature brands.

Why should I use the materials in Content Centre? Content Centre contains full assets with validated content ready for use. Content Centre provides complimentary assets which allow local markets the ability to easily deploy a multi-channel campaign. These complimentary assets are referred to as Content Packs. Going to Content Centre before creating new content reduces redundancies and provides a more efficient and cost-effective way of preparing an asset, obtaining local approval, and delivering to our external customers.

What are the metrics for success in Content Centre? User Satisfaction of Content

GPPS, GCA and other teams working with Content Centre

Downloads from Local Markets

Audit of reused materials

Page 6: Frequently Asked Questions Table of Contents · Frequently Asked Questions Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify

Frequently Asked Questions

Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify that

AstraZeneca owns the rights to reuse these assets/components and any files that are part of them for the context, location, and duration of your intended use.

Last Edit: July 14, 2017 Page 6

Accessing Content Centre

How do I access Content Centre? Content Centre may be accessed by going directly to the Content Centre platform or by navigating to the

Content Centre Welcome Page and using the links at the top of the page. . A job aid is also available on

the Content Centre Welcome page which provides detailed information on how to access content within

Content Centre. If you need access to Content Centre, please request via content-

[email protected].

What is the process for requesting Content Centre access for outside

agencies? Outside agencies must follow the Exostar process to gain access to Content Centre. The Exostar

process is as follows:

New User completes the User Request Form and sends it to [email protected].

A ticket is then created for the Exostar Team

The Exostar Team will create a profile and automated emails are sent to the User with Username,

Password & System Generated Password.

User will follow the instructions for the First Time Login and create a profile for Exostar.

Once the profile is created, Content Centre Help Desk forwards the request to the appropriate

team to activate the User in the Exostar tool. Once Exostar access is complete, Content Centre

Help Desk team will provide access to Content Centre and other tools.

User can use Exostar Username or their email address to access Tools.

How do I gain access to the security group for medical assets on Content

Centre? To gain access to Content Centre and the GMA (Global Medical Affair), security group, please email your

request to [email protected] and your request will be reviewed by the core team to

ensure proper compliance.

What measures are in place to prevent commercial teams from viewing

medical assets? Medical assets are provided with additional metadata that restricts their viewing to only those individuals

who are members of a custom security group. Access to this security group is tightly controlled and

monitored by the GMA and Content Centre teams. This is important as GMA material is not approved for

promotional use.

Can medical affairs personnel access commercial content? Yes, GMA personnel can access commercial content. However, commercial users cannot access medical

content.

Page 7: Frequently Asked Questions Table of Contents · Frequently Asked Questions Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify

Frequently Asked Questions

Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify that

AstraZeneca owns the rights to reuse these assets/components and any files that are part of them for the context, location, and duration of your intended use.

Last Edit: July 14, 2017 Page 7

Is Content Centre available in other languages? The Content Centre platform is available in English and Japanese. The language of assets in Content

Centre can vary. Validated Assets are available in English. Non-Validated Assets may be available in

additional languages.

Asset Availability and Planning

What are Validated Assets and Non-Validated Assets? Validated Assets are assets that are globally licensed and include all source files. These assets are

clearly structured for ease of reuse and are available in an editable format so that they can be easily

localised. These assets also include editable manuscripts with annotated citations. Content Centre

highlights Validated Assets more prominently to encourage local market reuse of globally validated

content. Validated Assets are clearly identified in Content Centre by a “Validated Asset” tile on the

thumbnail.

Non-Validated Assets have not been reviewed by the Content Centre team to ensure all source files are

present or globally licensed and may not be endorsed by GPPS.

How do I know when a new Validated Asset has been uploaded to Content

Centre? There are several channels used to communicate when new content is available.

1. The Content Centre Planning Calendar is updated to include a link to the asset in Content Centre.

Note: This is only available to internal users and not agencies.

2. A Promote email will be sent to local markets to inform users that a new asset has been uploaded

to Content Centre.

3. New Validated Assets are featured on the Content Centre home page, marked with a Validated

Asset icon within the thumbnail tile.

4. An email notification can be set up directly from the Content Centre. The Content Centre job aid

(on the Content Centre Welcome Page) provides instructions on how you can subscribe to email

notifications or you can open “My Profile” within Content Centre.

5. Recently uploaded Validated Assets are featured in Content Centre’s monthly newsletter, News

Flash. To be added to the distribution list, please email [email protected].

Can Non-Validated Assets be reused? Yes, a Non-Validated Asset can be reused. However, it will most likely require more effort than reusing a

Validated Asset since source files may or may not be included, licensing may not be global, and other

important information for reuse may be missing.

Non-Validated Assets are helpful when looking for inspiration or to see what other local markets have

created.

Page 8: Frequently Asked Questions Table of Contents · Frequently Asked Questions Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify

Frequently Asked Questions

Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify that

AstraZeneca owns the rights to reuse these assets/components and any files that are part of them for the context, location, and duration of your intended use.

Last Edit: July 14, 2017 Page 8

What types of assets will be available? Content Centre provides both promotional assets as well as learning assets. Brand assets that are

common across many markets, such as Core Visual Aids (CVAs), Interactive Detail Aids (iDAs), videos,

Mechanism of Action (MOA) videos, emails, and websites are some examples of promotional assets.

eLearning modules, slide decks, and assessments are some examples of learning assets. Brand assets

which are complimentary to each other are called Content Packs. This allows local markets the ability to

implement multi-channel campaigns easily.

Many of the brands also have an asset type called Branding Elements. This asset type contains logos,

Core Claims Guides, Brand Master Files, and high resolution versions of images.

How can I be sure I’m accessing the most recently approved assets? Validated Assets that appear first on brand pages as Validated Assets are the most recently approved

versions of the asset. Validated Assets have an icon underneath the thumbnail indicating that it is

validated content. Non-validated Assets do not have this indicator. When conducting a free text search,

the results show the most recently uploaded assets, therefore the Validated Asset icon is a helpful

indicator to differentiate between Validated and Non-validated assets. Local markets and local learning

managers can also check the Content Centre Planning Calendar to see when new assets are planned for

release.

Assets which were approved globally but have expired are indicated with a red exclamation point (!) in the

upper right-hand corner of the asset tile. Since all assets must be approved locally, these assets will

remain in Content Centre.

Can images be changed? A market can substitute artwork if there is not something applicable for their country. However, we

encourage local markets to consult their branding guidelines for additional guidance and check the

branding elements folder for possible additional images.

Who populates the planning calendar? The Content Centre team populates the calendar with feedback from the appropriate global team.

How do global teams evaluate which assets will be promoted to Content

Centre? GPPS in partnership with the Global Engagement Directors (GED; Rose Pimpinella for NA based GPPS

brands and Nichola Menzel for UK based GPPS brands) plan for assets being created that have potential

for reuse by local markets.

SCLA works closely with the Content Centre Planning Manager to review and promote out the curricula

to local learning managers which has the potential for reuse by local markets.

Page 9: Frequently Asked Questions Table of Contents · Frequently Asked Questions Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify

Frequently Asked Questions

Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify that

AstraZeneca owns the rights to reuse these assets/components and any files that are part of them for the context, location, and duration of your intended use.

Last Edit: July 14, 2017 Page 9

What is the process for GPPS/GDO and their Agency of Record (AoR) to

obtain Global Nominated Signatory approval? The AoR and GPPS team review the final assets produced by the Content Centre Production Partner

(CCPP) before submission to the Global Nominated Signatory for review.

For iDetails, the functional review will be done through the Veeva Sandbox. To review functional iDetails,

GPPS teams and their supporting AoRs will need access to the Global (EU) Veeva Sandbox Environment

to review the functional assets. Access can be requested by contacting IT-Service-Desk-

[email protected].

When an asset has been globally approved, it will still need to be locally approved once it is downloaded

to make sure that it is compliant with local standards

I don’t see my brand on Content Centre. How do I find out if/when my brand

will be available? Most brands that are supported by global teams will have content available through Content Centre over

time, including launch brands. You can check the planning calendar for information on when new brands

or assets will become available. Additionally, we invite you to check the Non-Validated Assets folder on

the Content Centre platform for potentially re-usable assets.

Are assets available for all local markets? Yes, apart from GMA assets such as Faslodex, which are only available to local market GMA teams.

However, all assets need to be approved by each local market Nominated Signatory.

How will an asset that has been approved globally be handled through the

local approval process? Once Validated Assets have been translated and localized, all assets must be submitted for local market

Nominated Signatory approval (AZAP for US market). eLearning content may not need local Nominated

Signatory approval. Please check with your compliance team if you are unsure.

Will assets be available in my language? All Validated Assets in Content Centre will be in English. However, GDO offers the opportunity for local

marketing teams to utilize preferred production suppliers for the translation of assets. Reach out to your

GDO Engagement Team for assistance in localisation.

If I am in a regional market, can I upload my asset(s) into Content Centre

for reuse in other markets? Local marketing teams should contact their respective GDO Regional Engagement Team who will work

with the Content Delivery Directors to determine if an asset should be included in Content Centre. If the

global team determines that the asset is content “rich” (containing multiple messages), has the potential

for global reuse, and therefore included in Content Centre as a Validated Asset, then Content Centre will

work with the local market and the global team to validate the content. This includes purchasing the

global rights and licenses, obtaining sources files for the local asset, and loading the asset into Content

Page 10: Frequently Asked Questions Table of Contents · Frequently Asked Questions Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify

Frequently Asked Questions

Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify that

AstraZeneca owns the rights to reuse these assets/components and any files that are part of them for the context, location, and duration of your intended use.

Last Edit: July 14, 2017 Page 10

Centre to allow other markets to reuse. Once local markets download the content and translate it, the

localised content will need to be locally approved. Only a local Nominated Signatory can approve in-

market materials.

Assets without global approval can still be uploaded into Content Centre. These assets will sit in the Non-

Validated section of Content Centre. In this case, brands should have their agencies send assets to the

Content Centre mailbox. These agencies should fill out the Non- Validated version of the MRF (available

on Content Centre) completely and provide necessary source files.

Local Learning managers can upload the localised and approved learning curricula into the Non-Validated

section of Content Centre by having their agencies send assets to the Content Centre mailbox. These

agencies should fill out the Non-Validated version of the MRF (available on Content Centre) completely

and provide necessary source files.

If the asset is not considered as a Validated Asset it may still be eligible as a Non-Validated Asset.

Are there any specific assets that the local agencies should search for in

Content Centre before developing it themselves? Local markets and local learning managers, along with their agencies, should search for assets that are

similar in type to the ones that they are creating. Agencies should also check other Validated Assets for

the same brand to see if any of the brand content can be leveraged. For instance, if content found within

an asset type (such as iDA) is deemed valuable for reuse, the content can be used for another asset type

(such as Congress materials). The same is true for elements contained within eLearnings modules. A

part of an eLearning module can be used in an iDA or congress materials as long as it is approved by the

local Nominated Signatory and unlimited rights are purchased. Most eLearnings curricula only have

limited rights purchased since they were developed originally for internal use.

How can I get the correct material, such as high resolution graphics, that

must be sent to the agency? Selecting “Yes” to the question "Include Associated Files?" during the download process will allow you to

get the fully editable source files. Validated Assets have been verified for complete source files. Non-

Validated Assets may not have complete files, so we encourage you to use the validated files as much as

possible. Selecting "No" to the question "Include Associated Files?" at download will result in the simple

download of a preview only. Source files are not included unless you choose "yes".

Does the completed Metadata Request Form (MRF) allow us to use the

asset at local level with all copyrights required? The MRF will provide details about the licensing as well as any information that the local market may

need to purchase. As far as possible, global licenses will have been obtained for promotional assets. For

eLearnings and other training assets, in most cases only global limited rights have been purchased, as

the original intent was for internal use only.

Page 11: Frequently Asked Questions Table of Contents · Frequently Asked Questions Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify

Frequently Asked Questions

Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify that

AstraZeneca owns the rights to reuse these assets/components and any files that are part of them for the context, location, and duration of your intended use.

Last Edit: July 14, 2017 Page 11

Is learning content also available on Content Centre? Both unbranded and branded learning assets are available and can be filtered by modality such as

eLearning, slide deck or assessments. Additionally, there are selling skills assets such as leadership

selling and Key Account Management assets available.

Who can I contact if I cannot find the learning material I am looking for? If you are unable to find learning material that you have been notified is on Content Centre, please

contact the Content Centre to remedy this issue. Please review the Content Centre Planning Calendar to

determine whether additional learning materials are in the planning or production phases.

Can I access learning material if I have already done Content Centre

training? If you already completed end user training and are using Content Centre for promotional material, you will

be able to view learning material. However, certain areas of the learning content are restricted based on

your role. If you are in a learning development role, you will be able to see learning assessments. If you

are in another type of role, you will not be able to access assessments.

How are learning materials displayed on Content Centre? Similar to promotional material, learning materials will be uploaded onto Content Centre in sections which

may be broken down further. When a large learning programme is added to Content Centre, it will likely

be available at the asset level that a user can go through with the assessments available separately.

Learning Managers should review the curriculum map available in the download package to ensure all

assets have been downloaded.

How do I recognise a medical asset verses a commercial one? Medical assets will have GMA flag in the upper left hand corner of the asset thumbnail. Additionally,

medical assets will be clearly shown in the title as well as having the asset type of Medical Materials.

Page 12: Frequently Asked Questions Table of Contents · Frequently Asked Questions Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify

Frequently Asked Questions

Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify that

AstraZeneca owns the rights to reuse these assets/components and any files that are part of them for the context, location, and duration of your intended use.

Last Edit: July 14, 2017 Page 12

Content Packs

What is a Content Pack? A Content Pack is a group of the most useful assets for a brand, created directly from the core story of a

content rich asset such as an iDA (interactive Detail Aid) or CVA (Core Visual Aid) (a ‘core’ or ‘parent’

asset). All assets in a Content Pack will be available in Content Centre within a very short time of the

core asset being produced.

In addition to a core asset, a Content Pack is comprised of additional asset types, such as an interactive

.pdf, HCP emails, HCP leave behinds, banners and web content to support MultiBrand.com.

A Content Pack offers our markets a broader range of consistent, globally created and approved, high

quality assets that are ready and easy to localise. This will save local teams time, money, and effort in

producing their materials.

What is the point / benefit of a Content Pack? A Content Pack saves global teams as well as local markets both time and money in the following ways:

Consistency: All assets developed follow brand guidelines and are platform and device agnostic

Supports Multi-Channel: Multiple assets based on same core story allows markets to maximize

multi-channel marketing efforts

Cost & Quality: Content Pack assets are internally created from globally approved content

Faster Time to Market: Parallel development of assets results in faster availability to local

markets

What if I would like an asset that is not included in the standard Content

Pack offering?

If you work in GPPS please contact the Global Engagement Director for your brand. They will be

delighted to talk to your team about Content Packs and share with you the asset options available. We

also encourage every GPPS team to reach out to the local markets to determine the best mix of assets

for their particular brand. We are able to offer some alternative assets to make up your Content Pack and

can therefore switch assets in and out of the pack to best suit your needs.

Alternative assets we offer are: RTE / VAE, dosing cards, reprint carriers, folders, journal ads, congress

panels, and PowerPoint presentations.

If you are in a market, please contact your GDO Regional Engagement Team contact. They will help you

with Content Packs that are already available. If you find an asset in Content Centre that is not part of a

Content Pack but is still relevant to your market, the GDO Contacts will take your feedback and use it to

help shape future Content Packs.

Page 13: Frequently Asked Questions Table of Contents · Frequently Asked Questions Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify

Frequently Asked Questions

Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify that

AstraZeneca owns the rights to reuse these assets/components and any files that are part of them for the context, location, and duration of your intended use.

Last Edit: July 14, 2017 Page 13

How can I influence what is offered in a Content Pack? Please speak to your GDO Engagement Contact. We are eager to provide a Content Pack with assets

that are of most value to the local markets, so please do provide your feedback so that we can improve

this offering.

What does a Content Pack cost? Subject to approval, the creation of Global Content Packs will be funded through the Spend Smart for

Growth (SS4G) initiative. Your GDO Engagement Director will discuss with you what can be included in a

Content Pack.

For local markets, you can contact your GDO Regional Engagement Team member to learn more about

the cost of localising a Content Pack asset.

For more information on the SS4G Initiative, see the SS4G section of the Content Centre Terminology

Document.

How long does it take to prepare a Global Content Pack? The overall time will depend on the types of assets selected to form a Content Pack. The benefit of

Content Packs is that the overall time get Content Packs to a local market will be significantly shorter than

leaving local markets to build content on their own, as well as providing local markets with cost benefits,

and ensuring strategic alignment.

Are Content Packs globally approved? Yes. All the assets produced as part of Content Packs have been reviewed by GPPS and have been

through the global approval process. However, as with all Content Centre assets, local review and

approval for use in market will also be required.

Where can I look at the Content Packs that are already available? Content Packs will be clearly identified in Content Centre with a Content Pack logo on the thumbnail of

each Content Pack asset. You will also be able to search using ”Content Pack” as a search term to see

all of the Content Packs that are currently available.

How do I know what other Content Packs are coming? The Content Centre Calendar will show which Content Pack assets will be available and when.

Additionally, the monthly Content Centre News Flash will alert you to new Content Pack assets. You may

also receive news directly from GPPS on their plans for Content Packs. Finally, an email notification can

be set up directly from the Content Centre. The Content Centre job aid (on the Content Centre Welcome

Page) provides instructions on how you can subscribe to email notifications or you can open “My Profile”

within Content Centre.

Please note that because Content Packs are a new offering from Content Centre, Content Packs will not

be available for all brands immediately. Content Packs will be created when GPPS has a new campaign

and plan to create or refresh an iDA or CVA. This will be a trigger for a Content Pack to be created.

Page 14: Frequently Asked Questions Table of Contents · Frequently Asked Questions Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify

Frequently Asked Questions

Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify that

AstraZeneca owns the rights to reuse these assets/components and any files that are part of them for the context, location, and duration of your intended use.

Last Edit: July 14, 2017 Page 14

What is the best way to localise the Content Pack assets? Global Digital Organisation (GDO) can help you to localise the Content Pack assets in a quick, efficient,

and cost effective way. Please speak to your GDO Regional Engagement Team member for more

information on this service.

Who can I talk to about working on and creating a Content Pack? If you work in GPPS, please contact the Global Engagement Director for your brand. They will be

delighted to talk to you about Content Packs and share with you the asset options available. If you are in

a market, please contact your GDO Regional Engagement Team member. They will help you with

Content Packs that already available or will take your feedback and use it to help shape future Content

Packs.

How do I access and download the Content Pack materials? Content Packs are clearly identified within Content Centre with a Content Pack logo located on the

thumbnail tile. You can also search using ‘Content Pack’ as a search term to see all the Content Pack

assets that are currently available. Once you see the Content Pack that you are interested in, you will

have the option to download the assets within it. You can either download a single asset or any number of

assets. A short training video is available within Content Centre to help you if you want to do a batch

(multiple asset) download. You can also contact Content Centre help if you are experiencing any issues.

Page 15: Frequently Asked Questions Table of Contents · Frequently Asked Questions Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify

Frequently Asked Questions

Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify that

AstraZeneca owns the rights to reuse these assets/components and any files that are part of them for the context, location, and duration of your intended use.

Last Edit: July 14, 2017 Page 15

Download Logistics

How long does it take to download the file? This inevitably varies with file size. However, AZ marketers will rarely need source files themselves, so

they can choose to download only a preview (often a .pdf or .mov) and send a link to their agency who

can download all the source files separately. Content Centre has implemented a file download

acceleration technology to ensure Content Centre downloads are as fast as currently possible within the

constraints of the local infrastructure. When a user receives an email notification that a download

package is available, the email will contain 2 links – one for the accelerated file download process and

one for the regular download process. The first time that the file accelerator process is used, a brief

installation process occurs; however, this is a one-time process.

Where do downloaded files end up? The user is required to select a file destination. The file name path cannot exceed 216 characters;

therefore, Content Centre recommends that you download files to your Desktop to limit the length of

the file name. However, this destination can be on a removable drive if required.

What do I need to download? Should I include associated files or not? In order to download only the preview files and not the complete package, please select “No” in

the Download Asset popup that is displayed after selecting the download option. This will be a

smaller, faster download package and will include all of the files needed to preview an asset.

In case you want to access the complete source files and associated documents, it is best to

select “Yes” to include associated files option. This download package is larger, but contains all of

the source files, reference lists, annotated citations, licenses, and global rights. After download,

please make sure you check the zip file in the Associated Files folder. This is where all the

source files are stored.

Can the associated source file download option be made default? The default option is currently not an option at the user level. In order to download source files, the user

needs to select “YES” for the “include associated files” option.

Are the reference documents present on Validated Assets? For copyright reasons, Content Centre downloads do not include PDF copies of reference documents.

However, all Validated Assets come with a fully referenced English language manuscript with annotated

citations. These annotated citations include page number and paragraph number so that anyone with a

PDF of the reference can see exactly where in the publication the reference is located. All reference

documents may be viewed within the global approval tool; however, these documents are not available

for download due to copyright restrictions.

Page 16: Frequently Asked Questions Table of Contents · Frequently Asked Questions Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify

Frequently Asked Questions

Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify that

AstraZeneca owns the rights to reuse these assets/components and any files that are part of them for the context, location, and duration of your intended use.

Last Edit: July 14, 2017 Page 16

Support

Who are the local Production Partners? There are several Preferred Production Partners to support the localisation and translation of content.

Contact the GDO Engagement Team in your area.

Is Content Centre going to make any content changes for the assets? Content Centre is responsible for the validation of the asset and for the HTML coding of iDAs, not the

content itself. Content is the responsibility of the global team. Content Centre will only make changes that

the global team or a localising market requests.

If the local marketing teams need help purchasing fonts, who do they reach

out to? If the fonts have not been purchased globally, then the local agency would buy the fonts on behalf of the

local markets. The details for purchase will be in the MRF as well as the Usage Rights Information section

on the Content Centre.

What other services does Content Centre provide? Content Centre can assist with testing and uploading of learning content on both the GCA Portal and

AZLearn. In addition, Content Centre can help add learners to your curriculum and provide you with

reporting. A special team named GDO Global Learning Services has been created to assist you with

these activities. Please reach out to them directly at [email protected].

Page 17: Frequently Asked Questions Table of Contents · Frequently Asked Questions Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify

Frequently Asked Questions

Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify that

AstraZeneca owns the rights to reuse these assets/components and any files that are part of them for the context, location, and duration of your intended use.

Last Edit: July 14, 2017 Page 17

Training

Who do I contact if I have questions? There are multiple ways to get Content Centre information and support from GDO:

Global Engagement Team

Contact the Content Centre mailbox [[email protected]]

Post a message in the Content Centre Chatter Group

For access to Content Centre platform send requests to: [email protected]

For assistance with the GCA Portal and SCLA developed learning content, contact

[email protected].

What Content Centre training will be provided and when? Content Centre offers eLearning modules for a variety of audiences. To view the offerings, please check

the Content Centre Welcome Page. If you are interested in additional information after completing the

training, please contact the Content Centre mailbox ([email protected]). Please note that

modules are hosted in AZ Learn. If you need access to AZ Learn, please contact the Content Centre

Mailbox ([email protected]).

Are agencies able to take eLearning modules? Yes, agencies are required to complete Content Centre training modules listed on the Content Centre

Welcome Page. Modules are hosted in AZ Learn. If you need access to AZ Learn, please contact the

Content Centre Mailbox ([email protected]).